Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001136261-19-000014
Filing Date
2019-01-28
Accepted
2019-01-28 17:12:51
Documents
2
Period of Report
2019-01-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1545
2 POWER OF ATTORNEY poaoconnor.htm EX-24 4385
  Complete submission text file 0001136261-19-000014.txt   7534
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 550 HILLS DRIVE 3RD FLOOR BEDMINSTER NJ 07921
Business Address
O'Connor Daniel J. (Reporting) CIK: 0001376847 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22245 | Film No.: 19546314